Zymeworks Inc. Common Shares (ZYME) Social Stream

Featured Post From StockTwits About ZYME

$GMAB $BOLT $ZYME $AZN $RHHBY Genmab CEO and CM (we're super excited abt the Bolt Biotherapeutics technology and platform. We are already working with them on a very large number of target programs. the partnership is a complementary strategy to the things that we have already been working on, either stand-alone or collaboration BioNTech. We have looked, at a number of companies that are working on this, and we felt that they were very much leading.
It's already clinically validated, Jonathan, in the HER2 space. This is very different from some other technology platforms. So, we are very, very excited. We have already, I think, more than several handful of potential targets we are pursuing, both at monospecific and with bispecific. So, I think there's definitely more to come here,.
I don't think we would, at this call, give any indications on targets, except that this is a very important cornerstone of our future strategy. )
https://www.fool.com/earnings/call-transcripts/2021/08/11/genmab-as-gmab-q2-2021-earnings-call-transcript/

What Else are ZYME Traders Talking About?

Other tickers frequently mentioned alongside ZYME are GMAB, BOLT, AZN and RHHBY.